bild
ARGENTINIEN CORONAVIRUS PHARMA LABOR MABXIENCE
epa08603485 Workers of the mAbxience laboratory, chosen by AstraZeneca for the production in Latin America of the vaccine against COVID-19, carry out tasks in the plant that the company owns in Garin, in the province of Buenos Aires, Argentina, 14 August 2020. The Argentine laboratory mAbxience is confident that the results of the clinical trial of the vaccine developed by AstraZeneca in collaboration with the British University of Oxford will be positive and that production will begin later this year or early 2021. EPA/Juan Ignacio Roncoroni
Instruktionen
Lizenz
Rights Managed
Erstellungsdatum
20200814
Ort
GARIN ARGENTINIEN
Credit
KEYSTONE
Source
EPA EFE
Byline
JUAN IGNACIO RONCORONI
Grösse
5219 x 3337 px
Dateityp
JPEG